See more : John Marshall Bancorp, Inc. (JMSB) Income Statement Analysis – Financial Results
Complete financial analysis of Envista Holdings Corp (NVST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Envista Holdings Corp, a leading company in the Medical – Equipment & Services industry within the Healthcare sector.
- OncoCyte Corporation (0KCC.L) Income Statement Analysis – Financial Results
- Balfour Beatty plc (BBY.L) Income Statement Analysis – Financial Results
- Eastern Platinum Limited (ELR.TO) Income Statement Analysis – Financial Results
- Sino Medical Sciences Technology Inc. (688108.SS) Income Statement Analysis – Financial Results
- JTEC Corporation (3446.T) Income Statement Analysis – Financial Results
Envista Holdings Corp (NVST)
About Envista Holdings Corp
Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
---|---|---|---|---|---|---|---|---|
Revenue | 2.57B | 2.57B | 2.51B | 2.28B | 2.75B | 2.84B | 2.81B | 2.79B |
Cost of Revenue | 1.12B | 1.09B | 1.08B | 1.12B | 1.24B | 1.24B | 1.19B | 1.18B |
Gross Profit | 1.45B | 1.47B | 1.43B | 1.16B | 1.51B | 1.60B | 1.62B | 1.60B |
Gross Profit Ratio | 56.52% | 57.41% | 56.86% | 50.75% | 54.99% | 56.31% | 57.68% | 57.48% |
Research & Development | 93.80M | 100.10M | 100.50M | 100.80M | 154.70M | 172.00M | 172.40M | 142.80M |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 1.06B | 1.06B | 1.02B | 1.02B | 1.08B | 1.13B | 1.06B | 1.06B |
Other Expenses | 268.30M | 3.10M | 2.40M | -900.00K | 1.50M | 2.70M | 100.00K | -1.10M |
Operating Expenses | 1.42B | 1.16B | 1.12B | 1.12B | 1.24B | 1.30B | 1.23B | 1.20B |
Cost & Expenses | 2.54B | 2.25B | 2.20B | 2.25B | 2.47B | 2.55B | 2.42B | 2.38B |
Interest Income | 0.00 | 38.40M | 54.10M | 62.50M | 3.50M | 0.00 | 0.00 | 0.00 |
Interest Expense | 63.40M | 38.40M | 54.10M | 62.50M | 3.50M | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 162.60M | 162.10M | 151.90M | 163.10M | 168.10M | 130.00M | 121.40M | 127.20M |
EBITDA | 171.10M | 484.40M | 460.50M | 205.60M | 447.10M | 454.80M | 508.10M | 530.00M |
EBITDA Ratio | 6.67% | 18.85% | 18.35% | 8.57% | 10.14% | 15.06% | 18.08% | 19.03% |
Operating Income | 31.50M | 319.20M | 306.20M | 33.30M | 110.90M | 298.40M | 386.60M | 402.80M |
Operating Income Ratio | 1.23% | 12.42% | 12.20% | 1.46% | 4.03% | 10.49% | 13.75% | 14.46% |
Total Other Income/Expenses | -86.40M | -35.30M | -51.70M | -63.50M | 39.80M | 2.70M | 100.00K | -1.10M |
Income Before Tax | -54.90M | 283.90M | 254.50M | -30.10M | 275.50M | 301.10M | 386.70M | 401.70M |
Income Before Tax Ratio | -2.14% | 11.05% | 10.14% | -1.32% | 10.01% | 10.59% | 13.76% | 14.42% |
Income Tax Expense | 45.30M | 45.90M | -9.00M | -63.40M | 57.90M | 70.40M | 85.60M | 129.70M |
Net Income | -100.20M | 243.10M | 263.50M | 33.30M | 217.60M | 230.70M | 301.10M | 272.00M |
Net Income Ratio | -3.90% | 9.46% | 10.50% | 1.46% | 7.91% | 8.11% | 10.71% | 9.77% |
EPS | -0.60 | 1.46 | 1.63 | 0.21 | 1.60 | 1.49 | 1.95 | 1.76 |
EPS Diluted | -0.60 | 1.34 | 1.48 | 0.20 | 1.60 | 1.49 | 1.95 | 1.76 |
Weighted Avg Shares Out | 166.90M | 162.90M | 161.20M | 159.60M | 136.20M | 154.60M | 154.60M | 154.60M |
Weighted Avg Shares Out (Dil) | 166.90M | 177.60M | 177.60M | 164.10M | 136.40M | 154.60M | 154.60M | 154.60M |
Envista to host Investor Event at the Envista Summit on February 16, 2024
Envista Schedules Fourth Quarter 2023 Earnings Call
New Strong Sell Stocks for December 21st
Envista Announces Participation in J.P. Morgan Healthcare Conference
Envista Holdings Corporation Appoints Three New Members to Leadership Team
Envista (NVST) Up 6.8% Since Last Earnings Report: Can It Continue?
Envista Announces Release of 2022 Sustainability Report
3 Stocks Primed to Get a Post-Halloween Lift
Envista (NVST) Q3 Earnings Miss Estimates, Gross Margin Down
Compared to Estimates, Envista (NVST) Q3 Earnings: A Look at Key Metrics
Source: https://incomestatements.info
Category: Stock Reports